Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

BCAB holding history

BioAtla, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCAB overviewAll 13F holders of BCABFull Q2 2026 holdings

Shares (Q2 2026)
6,201
Value
$25.7K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BCAB by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,201$25.7K<0.1%−1,310−17.4%ReducedConverted for a 1-for-50 splitHolders
Q1 2026375,569$60.5K<0.1%+149,885+66.4%AddedHolders
Q4 2025225,684$128.2K<0.1%+138,941+160.2%AddedHolders
Q3 202586,743$59.7K<0.1%+57,168+193.3%AddedHolders
Q2 202529,575$11.7K<0.1%−18,788−38.8%ReducedHolders
Q1 202548,363$16.8K<0.1%−2,497−4.9%ReducedHolders
Q4 202450,860$30.1K<0.1%+39,908+364.4%AddedHolders
Q3 202410,952$19.3K<0.1%−17,471−61.5%ReducedHolders
Q2 202428,423$38.9K<0.1%−18,904−39.9%ReducedHolders
Q1 202447,327$162.8K<0.1%−464−1.0%ReducedHolders
Q4 202347,791$117.6K<0.1%+25,173+111.3%AddedHolders
Q3 202322,618$38.5K<0.1%−1,977−8.0%ReducedHolders
Q2 202324,595$73.8K<0.1%+24,595NewHolders
Q1 20230$00.0%−3,071−100.0%Sold outHolders
Q4 20223,071$25.3K<0.1%−2,513−45.0%ReducedHolders
Q3 20225,584$43.0K<0.1%+5,584NewHolders
Q1 20220$00.0%−70,994−100.0%Sold outHolders
Q4 202170,994$1.39M<0.1%+31,441+79.5%AddedHolders
Q3 202139,553$1.16M<0.1%+37,289+1,647.0%AddedHolders
Q2 20212,264$96.0K<0.1%−264−10.4%ReducedHolders
Q1 20212,528$129.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.